Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann-Sophie Bohne

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Zeitschrift Fur Rheumatologie|January 23, 2023
[DMARD treatment and skin cancer : Recognition, state of knowledge and prevention]Katharina Drerup, Ann-Sophie Bohne, Regine Gläser
Dermatologie (Heidelberg, Germany)|October 9, 2024
["Red flags" during pregnancy-skin symptoms and their causes during pregnancy]Ann-Sophie Bohne, Katharina Antonia Langen, Regine Gläser
Journal of Cancer Research and Clinical Oncology|October 10, 2024
Quality of life under treatment with the immune checkpoint inhibitors ipilimumab and nivolumab in melanoma patients. Real-world data from a prospective observational study at the Skin Cancer Center KielCarolin Grote, Ann-Sophie Bohne, Christine Blome, et al.
Journal of Cutaneous Pathology|March 28, 2023
Rheumatoid neutrophilic dermatosis under treatment with the interleukin-6-receptor-antagonist sarilumab in a patient with seropositive rheumatoid arthritisMarion Jost, Thomas Schwarz, Ulrike Wehkamp, et al.
Acta Dermato-Venereologica|April 3, 2024
Tolerability of Narrow-band Ultraviolet-B Phototherapy for Different Dermatological Diseases in Relation to Co-medicationsAnna M Halupczok, Ann-Sophie Bohne, Sascha Gerdes, et al.
Journal of Cancer Research and Clinical Oncology|May 9, 2026
Sensitivity and prognostic significance of circulating tumor DNA (ctDNA) in stage I to III malignant melanomaAnn-Sophie Bohne, Marilena Heber, Franziska Axt, et al.
The Journal of Molecular Diagnostics : JMD|November 27, 2015
Varying Mutational Alterations in Multiple Primary MelanomasFriederike Egberts, Ann-Sophie Bohne, Sandra Krüger, et al.
Frontiers in Oncology|June 10, 2021
Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG StudyKatharina C Kähler, Ralf Gutzmer, Friedegrund Meier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2025
Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell CarcinomaJeremy Mo, Anne Zaremba, Andrisha-Jade Inderjeeth, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Zeitschrift Fur Rheumatologie|January 23, 2023
[DMARD treatment and skin cancer : Recognition, state of knowledge and prevention]Katharina Drerup, Ann-Sophie Bohne, Regine Gläser
Dermatologie (Heidelberg, Germany)|October 9, 2024
["Red flags" during pregnancy-skin symptoms and their causes during pregnancy]Ann-Sophie Bohne, Katharina Antonia Langen, Regine Gläser
Journal of Cancer Research and Clinical Oncology|October 10, 2024
Quality of life under treatment with the immune checkpoint inhibitors ipilimumab and nivolumab in melanoma patients. Real-world data from a prospective observational study at the Skin Cancer Center KielCarolin Grote, Ann-Sophie Bohne, Christine Blome, et al.
Journal of Cutaneous Pathology|March 28, 2023
Rheumatoid neutrophilic dermatosis under treatment with the interleukin-6-receptor-antagonist sarilumab in a patient with seropositive rheumatoid arthritisMarion Jost, Thomas Schwarz, Ulrike Wehkamp, et al.
Acta Dermato-Venereologica|April 3, 2024
Tolerability of Narrow-band Ultraviolet-B Phototherapy for Different Dermatological Diseases in Relation to Co-medicationsAnna M Halupczok, Ann-Sophie Bohne, Sascha Gerdes, et al.
Journal of Cancer Research and Clinical Oncology|May 9, 2026
Sensitivity and prognostic significance of circulating tumor DNA (ctDNA) in stage I to III malignant melanomaAnn-Sophie Bohne, Marilena Heber, Franziska Axt, et al.
The Journal of Molecular Diagnostics : JMD|November 27, 2015
Varying Mutational Alterations in Multiple Primary MelanomasFriederike Egberts, Ann-Sophie Bohne, Sandra Krüger, et al.
Frontiers in Oncology|June 10, 2021
Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG StudyKatharina C Kähler, Ralf Gutzmer, Friedegrund Meier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2025
Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell CarcinomaJeremy Mo, Anne Zaremba, Andrisha-Jade Inderjeeth, et al.
Pageof 1